Efficacy of Probiotics in Reducing Pathogenic Potential of Infectious Agents

Probiotics exhibit significant antivirulence properties that are instrumental in mitigating infectious agents not only within the gastrointestinal tract but also in other parts of the body, including respiratory and urogenital systems. These live microorganisms, beneficial to health when administered in appropriate quantities, operate through several key mechanisms to reduce the pathogenic potential of bacteria, viruses, and fungi. Probiotics effectively reduce colonization and infection severity by enhancing the host’s immune response and directly antagonizing pathogens. One of the major modes of action includes the disruption of quorum sensing pathways, which are essential for bacterial communication and the regulation of virulence factors. Additionally, probiotics compete with pathogens for adhesion sites on host tissues, effectively blocking the establishment and proliferation of infections within a host. This multifaceted interference with pathogen mechanisms highlights the therapeutic potential of probiotics in controlling infectious diseases and enhancing host resilience. This review provides a detailed analysis of these mechanisms, underscoring the potential of probiotics for therapeutic applications to enhance public health.